Скачать или смотреть A Review of Phacilitate's Automation SIG by CGTC, Novartis, Invetech and Miltenyi Biotec

Matthew Durdy, CBO at the Cell and Gene Therapy Catapult leads a panel of cell and gene therapy manufacturing global experts to discuss the 2017 Automation special interest group findings and how to move forward as an industry.

Rod Rietze, who supported the process automation for Novartis' Kymriah, gives an incredible synopsis of the five cornerstones of automation. distilled from two days of discussion amongst 150 people into a single slide...

1. When and how do you invest in automation?
2. Understanding and developing next-generation cell and vector processes
3. Significantly better understanding of your product
4. Data management, capture, use and analysis
5. Accelerating the integration of novel technologies

David Kneen at Invetech and Jason Jones of Miltenyi complete the panel and explore how the industry is going to work together to standardise and close processes, all the while keeping an eye on the end game of commercialisation.

Phacilitate's 2018 Automation SIG will continue these discussions on May 30-31.

For more details and to register visit https://www.phacilitateautomation.com/